+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Synthetic Hormones Market - Global Forecast 2026-2032- Product Image
Synthetic Hormones Market - Global Forecast 2026-2032- Product Image
New

Synthetic Hormones Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5533197
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The synthetic hormones market is rapidly evolving as technology, regulatory demands, and patient-focused care reshape priorities for senior leaders prioritizing resilience and growth. Understanding segment complexity and adapting to shifting operational environments are critical for sustained success.

Market Snapshot: Synthetic Hormones Market Growth and Potential

The global synthetic hormones market expanded from USD 1.17 billion in 2025 to USD 1.33 billion in 2026, maintaining strong momentum with a projected CAGR of 14.88% and expected to reach USD 3.11 billion by 2032. This growth reflects a combination of advances in scientific innovation, higher prevalence of chronic conditions, and the adoption of patient-centric healthcare models. For decision makers, these dynamics highlight new commercial opportunities and operational imperatives that require agile response to market shifts, regulatory evolution, and advancements in synthetic hormone production platforms.

Scope & Segmentation

  • Hormone Classes: Estrogen, insulin, and thyroid hormones are primary classes, with each presenting distinct molecular complexities, clinical applications, and monitoring requirements.
  • Applications: Segment scope encompasses contraception, diabetes, growth hormone deficiency, menopausal symptom management, and thyroid disorders, each demanding tailored clinical pathways and patient access models.
  • Technologies: Innovative synthesis methods include chemical synthesis—liquid-phase and solid-phase techniques—and advanced recombinant DNA production, each aligned to molecule attributes and formulation needs.
  • End User Channels: Distribution is segmented by clinics, hospitals, homecare (including nursing services and self-administered therapies), as well as retail and online pharmacy networks, reflecting diverse care delivery infrastructures.
  • Regions: Market coverage includes Americas, Europe, Middle East and Africa, and Asia-Pacific, each region shaped by unique regulatory requirements, payer landscapes, and manufacturing strengths.

Strategic Segmentation Relevance

For leadership teams, granular analysis of each segment is essential for optimizing investments and anticipating adoption trends. The selection of a hormone class combined with its delivery channel impacts market uptake speed and operational scaling. Technology choices at the segment level influence production cost, scalability, and the overall pace of innovation. Regional specialization adds further complexity, requiring close alignment of go-to-market strategies with local regulatory and commercial environments.

Key Takeaways: Actionable Insights for Decision Makers

  • Advances in expression systems and synthesis techniques are expanding the range of hormone therapies attainable within shorter development timelines and more adaptable production models.
  • Market differentiation now depends heavily on real-world data and extended product lifecycles, with a heightened focus on patient-centered delivery formats that support adherence and effectiveness in outpatient settings.
  • Supply chain continuity depends on modular manufacturing and diversification strategies, backed by proactive mapping of supplier capabilities and responses to regulatory or policy shifts affecting sourcing and distribution.
  • Regional market entry strategies must consider infrastructure maturity, the regulatory environment, and local manufacturing expertise to maximize commercial access.
  • Strategic partnerships through licensing, co-development, and contract manufacturing are valuable for sharing risk, leveraging expertise, and accelerating commercialization pathways in a volatile market.
  • Cross-functional collaboration among regulatory, R&D, manufacturing, and commercial teams enables faster adaptation and more effective response to regulatory and trade policy changes.

Tariff Impact: U.S. Trade Measures and Market Strategy

U.S. tariff measures introduced in 2025 changed the cost structure for synthetic hormones and disrupted global supply chains. Manufacturers dependent on imported inputs responded by adjusting procurement processes, renegotiating supply contracts, and expanding regional manufacturing investments. These factors prompted the adoption of sophisticated inventory and supply mapping practices, while encouraging collaboration with contract development and manufacturing organizations based outside U.S. borders. The combined effect has heightened supply chain flexibility and strengthened risk management for clinical manufacturing operations.

Methodology & Data Sources

This report utilizes a thorough methodology, drawing on primary interviews with subject matter specialists in clinical, regulatory, and manufacturing roles. Secondary research includes analysis of regulatory guidance, clinical advancements, and technical publications. All insights are validated through triangulation, integrating platform capabilities, delivery constraints, and expert perspectives for comprehensive, actionable results.

Why This Report Matters

  • Provides leadership with a clear, integrated framework for strategic decision-making across technology development, regulatory compliance, and regional strategy.
  • Delivers practical recommendations for managing supply risk in a highly changeable trade and regulatory landscape, guiding resource and capital planning.
  • Supports commercial teams with segmentation-driven insights, ensuring product offerings stay aligned with evolving end-user and channel requirements.

Conclusion

The synthetic hormones market will continue to transform, driven by technological progress, policy developments, and shifting patient expectations. Organizations that synchronize innovation, supply chain strategy, and regulatory alignment are well positioned to sustain relevance and capture advantage in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Synthetic Hormones Market, by Hormone Class
8.1. Estrogen
8.2. Insulin
8.3. Thyroid
9. Synthetic Hormones Market, by Technology
9.1. Chemical Synthesis
9.1.1. Liquid-Phase Synthesis
9.1.2. Solid-Phase Synthesis
9.2. Recombinant Dna Technology
9.2.1. Bacterial Expression Systems
9.2.2. Mammalian Cell Expression Systems
9.2.3. Yeast Expression Systems
10. Synthetic Hormones Market, by End User
10.1. Clinics
10.1.1. General Practice Clinics
10.1.2. Specialty Clinics
10.2. Homecare Settings
10.2.1. Nursing Service
10.2.2. Self-Administration
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Online Pharmacies
10.4.1. Over-The-Counter
10.4.2. Prescription-Based
10.5. Retail Pharmacies
10.5.1. Chain Pharmacies
10.5.2. Independent Pharmacies
11. Synthetic Hormones Market, by Application
11.1. Contraception
11.1.1. Combined Oral Contraceptive
11.1.2. Progestin Only Contraceptive
11.2. Diabetes
11.3. Growth Hormone Deficiency
11.3.1. Adult GHD
11.3.2. Pediatric GHD
11.4. Menopausal Symptoms
11.4.1. Hot Flashes
11.4.2. Osteoporosis
11.4.3. Vaginal Atrophy
11.5. Thyroid Disorders
11.5.1. Hyperthyroidism
11.5.2. Hypothyroidism
12. Synthetic Hormones Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Synthetic Hormones Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Synthetic Hormones Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Synthetic Hormones Market
16. China Synthetic Hormones Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. AbbVie Inc.
17.7. Amgen Inc.
17.8. AstraZeneca PLC
17.9. Bayer AG
17.10. Eli Lilly and Company
17.11. Endo Pharmaceuticals Inc.
17.12. Ferring B.V.
17.13. Gilead Sciences Inc.
17.14. IBSA Institut Biochimique SA
17.15. Ipsen S.A.
17.16. Johnson & Johnson
17.17. Lupin Pharmaceuticals Inc.
17.18. Merck & Co. Inc.
17.19. Merck KGaA
17.20. Novartis AG
17.21. Novo Nordisk A/S
17.22. Organon & Co.
17.23. Pfizer Inc.
17.24. Sanofi SA
17.25. Teva Pharmaceutical Industries Ltd.
17.26. Theramex
17.27. TherapeuticsMD Inc.
17.28. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL SYNTHETIC HORMONES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL SYNTHETIC HORMONES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL SYNTHETIC HORMONES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES SYNTHETIC HORMONES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA SYNTHETIC HORMONES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL SYNTHETIC HORMONES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ESTROGEN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INSULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INSULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INSULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY BACTERIAL EXPRESSION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MAMMALIAN CELL EXPRESSION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MAMMALIAN CELL EXPRESSION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MAMMALIAN CELL EXPRESSION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GENERAL PRACTICE CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GENERAL PRACTICE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GENERAL PRACTICE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY NURSING SERVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY NURSING SERVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY NURSING SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SELF-ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SELF-ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY SELF-ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY OVER-THE-COUNTER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY OVER-THE-COUNTER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRESCRIPTION-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PRESCRIPTION-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN ONLY CONTRACEPTIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN ONLY CONTRACEPTIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PROGESTIN ONLY CONTRACEPTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ADULT GHD, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ADULT GHD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY ADULT GHD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PEDIATRIC GHD, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PEDIATRIC GHD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY PEDIATRIC GHD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOT FLASHES, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOT FLASHES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HOT FLASHES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY OSTEOPOROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY OSTEOPOROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY VAGINAL ATROPHY, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY VAGINAL ATROPHY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY VAGINAL ATROPHY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HYPERTHYROIDISM, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HYPERTHYROIDISM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HYPERTHYROIDISM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HYPOTHYROIDISM, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HYPOTHYROIDISM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY HYPOTHYROIDISM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 143. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 144. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 145. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 146. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 148. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 149. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2032 (USD MILLION)
TABLE 150. AMERICAS SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 158. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 159. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 160. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 161. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 162. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 164. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 174. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 175. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 176. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 177. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 178. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2032 (USD MILLION)
TABLE 199. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 201. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 202. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 203. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 204. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 206. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 207. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 208. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 209. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 210. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 211. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 212. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 213. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2032 (USD MILLION)
TABLE 214. EUROPE SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 218. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 219. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 220. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2032 (USD MILLION)
TABLE 231. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 233. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 234. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 235. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 238. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 239. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 240. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 241. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 242. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 243. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 244. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 245. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2032 (USD MILLION)
TABLE 246. AFRICA SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 248. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 257. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 258. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2032 (USD MILLION)
TABLE 263. GLOBAL SYNTHETIC HORMONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 264. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 266. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 267. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 268. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 269. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 271. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 272. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 273. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 274. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 275. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 276. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 277. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 278. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2032 (USD MILLION)
TABLE 279. ASEAN SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2032 (USD MILLION)
TABLE 280. GCC SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 281. GCC SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 282. GCC SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 283. GCC SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 284. GCC SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 285. GCC SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 286. GCC SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 287. GCC SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 288. GCC SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 289. GCC SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 290. GCC SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 291. GCC SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 292. GCC SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 293. GCC SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 294. GCC SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2032 (USD MILLION)
TABLE 295. GCC SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 304. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 305. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 306. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 307. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 309. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 310. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMPTOMS, 2018-2032 (USD MILLION)
TABLE 311. EUROPEAN UNION SYNTHETIC HORMONES MARKET SIZE, BY THYROID DISORDERS, 2018-2032 (USD MILLION)
TABLE 312. BRICS SYNTHETIC HORMONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 313. BRICS SYNTHETIC HORMONES MARKET SIZE, BY HORMONE CLASS, 2018-2032 (USD MILLION)
TABLE 314. BRICS SYNTHETIC HORMONES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 315. BRICS SYNTHETIC HORMONES MARKET SIZE, BY CHEMICAL SYNTHESIS, 2018-2032 (USD MILLION)
TABLE 316. BRICS SYNTHETIC HORMONES MARKET SIZE, BY RECOMBINANT DNA TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 317. BRICS SYNTHETIC HORMONES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 318. BRICS SYNTHETIC HORMONES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 319. BRICS SYNTHETIC HORMONES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2032 (USD MILLION)
TABLE 320. BRICS SYNTHETIC HORMONES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 321. BRICS SYNTHETIC HORMONES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 322. BRICS SYNTHETIC HORMONES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 323. BRICS SYNTHETIC HORMONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 324. BRICS SYNTHETIC HORMONES MARKET SIZE, BY CONTRACEPTION, 2018-2032 (USD MILLION)
TABLE 325. BRICS SYNTHETIC HORMONES MARKET SIZE, BY GROWTH HORMONE DEFICIENCY, 2018-2032 (USD MILLION)
TABLE 326. BRICS SYNTHETIC HORMONES MARKET SIZE, BY MENOPAUSAL SYMP

Companies Mentioned

The key companies profiled in this Synthetic Hormones market report include:
  • Abbott Laboratories
  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Eli Lilly and Company
  • Endo Pharmaceuticals Inc.
  • Ferring B.V.
  • Gilead Sciences Inc.
  • IBSA Institut Biochimique SA
  • Ipsen S.A.
  • Johnson & Johnson
  • Lupin Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Organon & Co.
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Theramex
  • TherapeuticsMD Inc.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.33 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.11 Billion
Compound Annual Growth Rate14.8%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Synthetic Hormones Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Synthetic Hormones Market Report 2025 - Product Image

Synthetic Hormones Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Synthetic Hormones Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Synthetic Hormones Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Bioidentical Hormones Market - Global Forecast 2026-2032 - Product Image

Bioidentical Hormones Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Human Growth Hormone Market Report and Forecast 2025-2034 - Product Image

Human Growth Hormone Market Report and Forecast 2025-2034

  • Report
  • 350 Pages
  • Global
From

About the Market

The Synthetic Hormone market is a subset of the Endocrine and Metabolic Disorders Drugs market. Synthetic Hormones are drugs that are designed to mimic the effects of naturally occurring hormones in the body. These drugs are used to treat a variety of endocrine and metabolic disorders, such as diabetes, thyroid disorders, and growth hormone deficiencies. Synthetic Hormones are also used to treat menopausal symptoms, such as hot flashes and night sweats. Synthetic Hormones are typically administered orally, through injections, or through topical creams. The market for Synthetic Hormones is expected to grow in the coming years due to the increasing prevalence of endocrine and metabolic disorders, as well as the aging population. Some companies in the Synthetic Hormone market include Novo Nordisk, Eli Lilly, Merck, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.